Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs01:25

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

1.6K
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
1.6K
Allergic Reactions02:06

Allergic Reactions

31.4K
Overview
31.4K
Cross-reactivity00:42

Cross-reactivity

32.5K
Overview
32.5K
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

1.0K
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
1.0K
Antigens Involved in Adaptive Immunity01:26

Antigens Involved in Adaptive Immunity

1.1K
An antigen is any substance the immune system identifies as foreign and potentially harmful to the body, prompting an immune response. Antigens have two functional properties: immunogenicity and reactivity. Immunogenicity is the ability of an antigen to stimulate a specific immune response. At the same time, reactivity describes the antigen's ability to react with the cells and antibodies produced in response to it.
Complete Antigens
Complete antigens possess both immunogenicity and...
1.1K
Allergic Drug Reactions01:27

Allergic Drug Reactions

1.2K
Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing...
1.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

New Structural Insights Into the Potency and Cross-Reactivity of the Major Peanut Allergen Ara h 2.

Allergy·2026
Same author

Allergic Sensitization to Inhalant Allergens in the Upper Respiratory Tract-the B Cell Side.

Allergy·2026
Same author

Transcriptomic Profiles of the Nasal Mucosa Following Birch Pollen Provocation Differ Between Birch Pollen-Allergic and Non-Allergic Individuals.

Allergy·2024
Same author

The epithelial barrier theory and its associated diseases.

Allergy·2024
Same author

Modulation of Bronchial Epithelial Barrier Integrity by Low Molecular Weight Components from Birch Pollen.

International journal of molecular sciences·2024
Same author

Legends of allergy and immunology: Otto Scheiner.

Allergy·2024

Related Experiment Video

Updated: Dec 10, 2025

Humanized Mediator Release Assay as a Read-Out for Allergen Potency
10:22

Humanized Mediator Release Assay as a Read-Out for Allergen Potency

Published on: June 29, 2021

3.8K

Advances and novel developments in molecular allergology.

Öykü Üzülmez1, Tanja Kalic1, Heimo Breiteneder1

  • 1Institute of Pathophysiology and Allergy Research, Medical University of Vienna, Vienna, Austria.

Allergy
|September 4, 2020
PubMed
Summary

Recent advancements in allergen discovery and immunotherapy offer improved diagnostics and treatments. Understanding allergen structure and function is key to developing novel allergy management strategies.

Keywords:
allergen immunotherapybiomarkers in allergyhypoallergensmarker allergensmechanisms of allergic sensitization

More Related Videos

Application of Biochip Microfluidic Technology to Detect Serum Allergen-specific Immunoglobulin E sIgE
07:10

Application of Biochip Microfluidic Technology to Detect Serum Allergen-specific Immunoglobulin E sIgE

Published on: April 21, 2019

16.8K
Removal and Replacement of Endogenous Ligands from Lipid-Bound Proteins and Allergens
09:09

Removal and Replacement of Endogenous Ligands from Lipid-Bound Proteins and Allergens

Published on: February 24, 2021

3.2K

Related Experiment Videos

Last Updated: Dec 10, 2025

Humanized Mediator Release Assay as a Read-Out for Allergen Potency
10:22

Humanized Mediator Release Assay as a Read-Out for Allergen Potency

Published on: June 29, 2021

3.8K
Application of Biochip Microfluidic Technology to Detect Serum Allergen-specific Immunoglobulin E sIgE
07:10

Application of Biochip Microfluidic Technology to Detect Serum Allergen-specific Immunoglobulin E sIgE

Published on: April 21, 2019

16.8K
Removal and Replacement of Endogenous Ligands from Lipid-Bound Proteins and Allergens
09:09

Removal and Replacement of Endogenous Ligands from Lipid-Bound Proteins and Allergens

Published on: February 24, 2021

3.2K

Area of Science:

  • Immunology
  • Allergology
  • Structural Biology

Background:

  • Allergenicity research is crucial for understanding and managing allergic diseases.
  • Novel diagnostic and immunotherapy approaches are continuously being developed.
  • Structural insights into allergens aid in understanding cross-reactivity and allergenicity.

Purpose of the Study:

  • To review recent developments in allergen and epitope discovery.
  • To discuss advancements in allergy diagnostics and immunotherapy.
  • To highlight research into the mechanisms of allergic sensitization.

Main Methods:

  • High-throughput sequencing, liposomal nanoallergen display, bead-based assays, and protein chimeras for epitope discovery.
  • Analysis of natural ligand binding to allergens (e.g., Bet v 1, Alt a 1) and its effect on stability and allergenicity.
  • Component-resolved diagnostics, basophil activation tests, and novel technologies for diagnostic improvement.

Main Results:

  • Structural information elucidates cross-reactivity of marker and nonhomologous allergens (e.g., Jug r 6, Ara h 1, Ara h 2).
  • Natural ligand binding enhances allergen stability, directly correlating with allergenicity.
  • New diagnostic approaches and immunotherapies, including virus-like particles and novel adjuvants, are emerging.

Conclusions:

  • Advances in allergen discovery and structural biology are improving allergy diagnostics and immunotherapy.
  • Understanding allergen-ligand interactions provides critical insights into allergenicity.
  • Research into sensitization mechanisms, like the roles of dectin-1 and formyl peptide receptor 3, is advancing allergy management.